Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 14, 2022
- Accession no.
- 0001209191-22-018591
- Filed
- Mar 14, 2022
- Trade date
- Mar 10-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $897.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | PPurchaseAcquired | +37,911 | $20.57 | +$779,829.27 | 522,576 | Indirect | |
| Mar 10, 2022 | Common Stock | PPurchaseAcquired | +2,489 | $21.23 | +$52,841.47 | 525,065 | Indirect | |
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +3,110 | $20.93 | +$65,092.3 | 528,175 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.